Winship Logo

Clinical Trial Details

Back to clinical trials
Phase Expanded AccessNot Applicable

RESQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guerin in Non Muscle Invasive Bladder Cancer

Protocol: STUDY00009415

Overview

Primary Objective:

  • To provide rMBCG to patients with NMIBC who are eligible to receive TICE® BCG, may benefit from its use, and who are ineligible to participate in a clinical trial using rMBCG.
Investigators
Shreyas Joshi
Locations
Emory University Hospital Midtown
Emory Saint Joseph's Hospital
Winship Cancer Institute